Table 1 Ovicidal activity of type I BZDs on an ABZ-susceptible isolate of Fasciola hepatica at a concentration of 50 µM
From: New benzimidazole derivative compounds with in vitro fasciolicidal properties
| |||
|---|---|---|---|
R1 | R2 | Compound identification | % Ovicidal activity |
H | 4′-OMe | BZD01 | 20.07 ± 9.32 |
H | 4′-Cl | BZD02 | 09.55 ± 5.68 |
H | 4′-Br | BZD03 | 01.93 ± 1.11 |
5-Me | 4′-OMe | BZD04 | 99.57 ± 0.43 |
5-Me | 4′-Cl | BZD05 | 35.59 ± 9.00 |
5-Me | 2′,5′-diMe | BZD06 | 02.26 ± 1.30 |
5-Me | 3′-NO2,4′-OMe | BZD07 | 07.13 ± 3.45 |
5-Cl | 4′-OMe | BZD08 | 98.08 ± 1.06 |
5-Cl | 4′-Cl | BZD09 | 04.96 ± 1.22 |
5-Cl | 4′-NO2 | BZD10 | 23.55 ± 8.06 |
5-Cl | 2′,5′-diMe | BZD11 | 03.28 ± 1.45 |
5-Cl | 3′-NO2,4′-OMe | BZD12 | 00.55 ± 9.45 |
5-Cl | 3′-NH2,4′-OMe | BZD13 | 04.40 ± 1.38 |
5-NO2 | 4′-OMe | BZD14 | 15.55 ± 7.35 |
5-NO2 | 4′-Cl | BZD15 | 24.32 ± 10.58 |
5-NO2 | 2′,5′-diMe | BZD16 | 00.33 ± 0.33 |
5-NO2 | 3′-NO2,4′-OMe | BZD17 | 00.00 ± 0.00 |
5-NH2 | 4′-OMe | BZD18 | 02.82 ± 1.42 |
5-NHCOPicol | 4′-OMe | BZD19 | 13.61 ± 3.64 |
5-OMe | 4′-OMe | BZD20 | 87.02 ± 3.64 |
5-OMe | 4′-Cl | BZD21 | 06.88 ± 6.88 |
6-OMe | 4′-Br | BZD22 | 67.47 ± 5.64 |
5,6-diMe | 4′-OMe | BZD23 | 59.08 ± 3.79 |
5,6-diCl | 4′-OMe | BZD24 | 16.09 ± 6.50 |
